From Medscape Diabetes & Endocrinology

Coverage from the

European Association for the Study of Diabetes (EASD) 2019 Annual Meeting

September 16 - 20, 2019; Barcelona, Spain

September 16 - 20, 2019 Barcelona, Spain
  • EASD 2019 PRIORITY: Urine Test Spots Future Kidney Disease in Diabetes Proteomic test identified patients with diabetes at high risk of kidney disease before they had detectable microalbuminuria. However, spironolactone did not mitigate the risk.
  • EASD 2019 Insulin Degludec Fails to Best Glargine in CONCLUDE Study Overall hypoglycemic episodes didn't differ in a head-to-head trial of the two second-generation basal insulin analogs, but both nocturnal and severe episodes were reduced with degludec.
  • EASD 2019 Bariatric Surgery in Obese Type 1 Diabetes Has Pros, Cons Large registry study in Sweden sheds light on risks and benefits of bariatric surgery in patients with type 1 diabetes, stresses it's important to evaluate potential candidates on a case-by-case basis.

Meeting Highlights At A Glance

  • Top News From EASD 2019: Slideshow Top News From EASD 2019: Slideshow Support for early combination therapy in newly diagnosed type 2 diabetes and "stunning" benefits with dapagliflozin in heart failure featured prominently this year.

Conference News

Medscape Diabetes© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News from EASD 2018